StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note published on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Trading Up 5.8 %
Shares of NASDAQ AEZS opened at $3.29 on Friday. The stock has a fifty day simple moving average of $2.89 and a two-hundred day simple moving average of $3.26. Aeterna Zentaris has a 1-year low of $3.96 and a 1-year high of $12.00. The firm has a market cap of $5.90 million, a price-to-earnings ratio of -0.22 and a beta of 1.55.
About Aeterna Zentaris
Further Reading
- Five stocks we like better than Aeterna Zentaris
- Using the MarketBeat Stock Split Calculator
- How to Build the Ultimate Everything ETF Portfolio
- Canada Bond Market Holiday: How to Invest and Trade
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- 3 Monster Growth Stocks to Buy Now
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.